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Granulomas are the hallmark of Mycobacterium tuberculosis (M.tb) infection and thus
sit at the center of tuberculosis (TB) immunopathogenesis. TB can result from either
early progression of a primary granuloma during the infection process or reactivation of
an established granuloma in a latently infected person. Granulomas are compact, orga-
nized aggregates of immune cells consisting of blood-derived infected and uninfected
macrophages, foamy macrophages, epithelioid cells (uniquely differentiated macrophages),
and multinucleated giant cells (Langerhans cells) surrounded by a ring of lymphocytes.The
granuloma’s main function is to localize and contain M.tb while concentrating the immune
response to a limited area. However, complete eradication does not occur sinceM.tb has its
own strategies to persist within the granuloma and to reactivate and escape under certain
conditions. Thus M.tb-containing granulomas represent a unique battlefield for dictating
both the host immune and bacterial response.The architecture, composition, function, and
maintenance of granulomas are key aspects to study since they are expected to have a
profound influence on M.tb physiology in this niche. Granulomas are not only present in
mycobacterial infections; they can be found in many other infectious and non-infectious
diseases and play a crucial role in immunity and disease. Here we review the models
currently available to study the granulomatous response to M.tb.
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INTRODUCTION
An estimated one-third of the world’s population carries an
asymptomatic infection with Mycobacterium tuberculosis (M.tb),
which results in eight million new cases of tuberculosis (TB) and
two million deaths every year (WHO, 2011). Granulomas are
the hallmark of M.tb infection and thus sit at the center of TB
immunopathogenesis. TB can result from either early progres-
sion of a primary granuloma during the infection process (rare)
or reactivation of an established granuloma in a latently infected
person (10% lifetime risk in an otherwise healthy individual).
Granulomas are well-organized, dynamic structures with
immune cells at various stages of differentiation (Figure 1).
The cellular composition of TB granulomatous lesions
includes blood-derived infected and uninfected macrophages,
foamy macrophages, epithelioid cells (uniquely differentiated
macrophages), and multinucleated giant cells (Langerhans cells), B
and T lymphocytes, and fibroblasts (Russell, 2007; Ramakrishnan,
2012).
In human pulmonary TB, the granuloma formation process
starts shortly after infection. When inhaled, M.tb is ingested by
and transported across the alveolar epithelium by AMs into the
lung tissue and adjacent lymph nodes, and then dissemination
ensues through the lymphatics and blood stream. This process
initiates a cascade of events involving the production of pro
and anti-inflammatory cytokines and chemokines. The immune
response generated stimulates the activation of phagocyte anti-
microbial activities and leads to the recruitment of additional
mononuclear leukocytes into the site of infection. This accumula-
tion of cells around the foci of infected cells leads to the formation
of a macrophage-rich cell mass known as a granuloma.
Mycobacterium tuberculosis can persist for decades within the
granuloma structures and, due to some intervening medical
(e.g., HIV infection, diabetes, cancer, malnutrition, aging, etc.)
and/or genetic factors, bacteria can reactivate. A balance of pro-
inflammatory and anti-inflammatory immune responses is essen-
tial for controlling bacterial proliferation within granulomas and
the resolution of these granuloma lesions over time. A dysregula-
tion in the immune response will lead to granuloma progression
and disease. An accumulation of caseum in the center of the gran-
uloma promotes an increase in necrotic tissue and the collapse of
the granuloma center which releases virulent bacilli to other parts
of the tissue where more lesions will be formed. In the lungs, break-
down of the granuloma into the airways can lead to transmission
of bacteria to other individuals.
In general, the production of chemokines is essential for the
recruitment of inflammatory cells to the site of infection (Algood
et al., 2003). Particularly, the chemokines binding to the CCR2
receptor (CCL2/MCP-1, CCL12, and CCL13) play an essential role
for the early recruitment of macrophages. During the early stages
of granuloma formation, TNF produced by infected macrophages
www.frontiersin.org April 2013 | Volume 4 | Article 98 | 1
Guirado and Schlesinger Modeling the Mycobacterium tuberculosis granuloma
FIGURE 1 |Typical architecture of aTB granuloma. (A) Representative granuloma with central necrosis from minipig lung tissue. Histological samples were
formalin-fixed, cut, and stained with hematoxylin-eosin. Adapted from Gil et al. (2010). (B) Schematic of the cellular constituents of a TB granuloma.
and T cells plays a crucial role in maintaining the granuloma
structure by keeping sustained levels of chemokines and cellu-
lar recruitment and retention (Roach et al., 2002; Chakravarty
et al., 2008). The accumulation of infected antigen presenting cells
(macrophages and dendritic cells) in the regional lymph nodes
leads to the development of the adaptive immune response against
M.tb. Briefly, a type 1 T helper (TH1) immune response is gen-
erated and CD4 T cells secrete IFNγ, IL-2, and lymphotoxin A.
Additional types of T cells also contribute to the immune response
against M.tb infection, including CD8 T cells and γδ T cells. How-
ever, granulomas develop during experimental infection in mice
deficient in these cells (D’Souza et al., 2000; Mogues et al., 2001).
CD8 T cells seem to be more important, at least in the mouse
model, at later stages by producing IFNγ and inducing cytotoxic
activity (Lazarevic and Flynn, 2002) once the bacillary growth is
stable. It has been proposed that while the early stages of infec-
tion are marked by M1 macrophage polarization, mostly due to
IFNγ secretion, providing the macrophages their mycobactericidal
capacity, the later stages promote a shift toward M2 polarization
as a consequence of several factors, including PPARγ and STAT6
expression (Lugo-Villarino et al., 2012). This scenario would be
predicted to contribute to the formation of foamy macrophages
(CD36 expression) and giant cells. Although granuloma formation
has long been thought to be a host-driven process, more studies
indicate that there is an active role played by M.tb (Davis and
Ramakrishnan, 2009).
Several studies have been unraveling the role of the recently
identified Th17 immune response within M.tb granulomas. Theγδ
T cell population is a major source of early IL-17 during mycobac-
terial infections (Lockhart et al., 2006; Umemura et al., 2007),
especially upon high dose infection (Hamada et al., 2008). IL-17
is most commonly associated with a pro-inflammatory response
and it has been suggested to play a role during early stages
of the granuloma formation promoting PMN recruitment and
organization around the foci of infection (Seiler et al., 2003; Tor-
rado and Cooper, 2010). Neutrophils and macrophages cooperate
for efficient mycobacterial killing (Silva, 2010).
During the aging process there are alterations in the immune
system that affect T cell functions such as decreased cytokine
production (IL-2 and IFNγ), cytotoxic activity, and T cell pro-
liferation. Animal models, more specifically the mouse model,
have clearly documented the relationship between age-related
decreased T cell responses and the increased risk of infection
by M.tb, as well as the negative impact of dysregulated immune
responses during M.tb chronic infection (Turner et al., 2001a,b;
Turner and Orme, 2002). Other factors such as other diseases
(e.g., diabetes mellitus), poor nutrition, and immunosuppression
also impact the protective granulomatous response against M.tb
infection during aging (Yoshikawa, 1992).
Histologically, there are different types of granulomas. Initially,
epithelioid cells may be surrounded by an acellular necrotic region,
with a ring of B and T cells. The granulomas can displace parenchy-
mal tissue and may necrotize, caseate, and/or calcify. Caseous
granulomas might turn calcified during chronic or latent infec-
tion. Other types of granulomas may not have a necrotic area
and are composed primarily of macrophages and a few lym-
phocytes. Host-pathogen interactions in the granuloma over the
course of infection lead to adaptive changes of the tubercle bacilli,
phenotypes of the host immune cells, and levels of the immune
mediators they produce. These features allow for the formation
of a wide spectrum of granuloma structures even within a single
human host, therefore implying the presence of several unique
microenvironments for M.tb as well as for the immune response.
On the one hand, the granuloma’s main function is to local-
ize and contain M.tb while concentrating the immune response
to a limited area. On the other hand, complete eradication does
not occur since M.tb has its own strategies to persist within the
granuloma and to reactivate and escape under certain conditions.
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Thus M.tb-containing granulomas represent a unique battlefield
for dictating both the host immune and bacterial response. Bac-
terial dissemination outside of the lungs that normally follows
primary infection allows for granuloma formation in many tissue
sites throughout the body, again representing different immune
microenvironments. The immune microenvironment which is
highly dependent on the tissue location and associated cells,
growth factors, and cytokines present will determine the pattern
of differentiation of the cells forming granulomas, especially the
macrophages. If the antigen load at the initial site of infection
and regional lymph node is large, necrosis and caseum develop
which represent signatures of M.tb granulomas. Reactivation TB
occurs in the lungs 80% of the time, whereas in 20% of cases, TB
reactivates at other tissue sites (e.g., pleural space, lymph nodes,
bone, kidney, etc) (Frieden et al., 2003), a consequence of the
early dissemination process that occurs during primary infection.
Tuberculous lymphadenitis is one of the most common forms of
all extrapulmonary TB.
Differentiating the protective mechanisms involved in the
mycobacterial granulomatous response from those causing tissue
damage and M.tb spread is crucial for the TB field. The architec-
ture, composition, function, and maintenance of granulomas are
key aspects to study since they are expected to have a profound
influence on M.tb physiology in this niche. Current knowledge
about the development and maintenance of granulomas in TB is
limited. However, several approaches are being pursued recently
to gain more insight into the events occurring within TB granu-
lomas. Here we review the models currently available to study the
granulomatous response to M.tb.
MODELING THE M.tb GRANULOMA
Use of models to study M.tb granulomas that resemble those in
humans is necessary because: (1) it is difficult to study human
lung biopsy samples since their access is often limited; (2) human
biopsy samples provide a static image that needs to be extrapo-
lated in order to understand the dynamic processes that take place
within the granuloma; and (3) M.tb lacks a natural host beyond
humans and, therefore, surrogate models are necessary that more
or less resemble human granulomas. These models are classified
as in vivo, in vitro, and in silico models (See Table 1).
IN VIVO MODELS
Animal models are often used to study the TB granulomatous
response. These models reproduce several of the processes occur-
ring in humans, although important differences are frequently
observed.
Mice
The mouse is the most popular animal model of M.tb infection.
The advantages of this model include size, availability and cost,
the abundant immunological tools and reagents available, and the
potential for manipulation, including use of inbred, genetically
modified strains (Orme, 2003). The large number of mouse mod-
els generated for infection has contributed to our understanding
of the granulomatous response to M.tb. The most relevant is the
low inoculum aerosol infection model because the aerosol route
mimics the natural route of infection in humans.
Resistant strain C57BL/6 mice infected intravenously or via
aerosol with moderate or low-dose inocula, respectively, develop
a chronic, progressive infection with M.tb (North and Jung, 2004;
Orme, 2005; Basaraba, 2008), with the presence of non-replicating
bacilli (Rees and Hart, 1961; Wallace, 1961; Munoz-Elias et al.,
2005). By 21 days post infection, a mycobacterial burden plateau
is reached (∼105–107 CFU) followed by a steady state of infection
maintained for more than 1 year (Rhoades et al., 1997). However,
despite the mice surviving the infection for a long time, where the
bacillary load is initially controlled due to a strong TH1 immune
response, progressive infiltration of the lung and other tissues
occurs due to changes in innate and adaptive immunity with age
toward a more TH0–TH2 immune response (Cardona et al., 2000,
2003) and eventually all of the mice die from TB. This latter obser-
vation has led many to question the utility of the standard mouse
model for studying granulomas in latency (Flynn, 2006).
The second mouse model widely used to study latent TB infec-
tion (LTBI) is the Cornell model. It is characterized by a high
intravenous injection of 1–3× 106 virulent M.tb followed by iso-
niazid and pyrazinamide treatment for 20 weeks (McCune and
Tompsett, 1956; McCune et al., 1956). Despite obtaining non-
culturable M.tb after treatment, mice are capable of developing
spontaneous or induced reactivation after 90 days (McCune et al.,
1966). The lack of a standardized protocol for establishing latency
with the Cornell model and the lack of stability are significant
disadvantages. Factors that can alter the outcome are the genetic
background of the mouse strain used, strain of M.tb used, inocu-
lum preparation protocol, route of infection, and the time between
infection and treatment (Scanga et al., 1999).
Given the relatively high bacterial load and progressive pathol-
ogy, these two models are recognized better for resembling a
chronic infection, rather than a human latent infection. How-
ever, the features of low-dose aerosol infection, healthy appearing
infected mice, and episodes of reactivation are generally con-
sistent with human LTBI. Another limitation of the standard
mouse model is the lack of structure and organization of the
granulomas formed which do not resemble human granulomas.
Granulomas in most mouse strains are formed by loose non-
necrotic cellular aggregates, a discrete fibrotic reaction, lack of
encapsulation, and a strong lymphocyte presence (Rhoades et al.,
1997).
Recently, new models have been developed where granulomas
develop necrotic lesions in response to M.tb infection and thereby
resemble granulomas in humans more closely (Pichugin et al.,
2009; Reece et al., 2010; Driver et al., 2012; Harper et al., 2012).
Intravital microscopy studies have revealed the dynamic nature
of mouse TB granulomas through three-dimensional time-lapse
microscopy which show activated T cells entering and moving
throughout the granuloma among relatively fixed macrophages
(Egen et al., 2008, 2011). A relatively new approach to study
cell traffic, repopulation, and the relationship between systemic
immunity and mycobacteria-containing granulomas is the granu-
loma transplantation model (Harding et al., 2011). In this model, a
mouse liver infected with BCG or M.tb is transplanted by surgical
insertion underneath the recipient’s kidney capsule. Interesting,
new insight is being provided by this model. However, the surgical
procedure, immune reaction to physical stress, length of survival
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Table 1 | Models to studyM.tb granulomas.
Models Advantages Disadvantages
Mice* Inexpensive, easy to handle, genetic variant strains, large
number of immunological tools, and reagents available
Lack of necrosis, lack of cell structure and organization that
resemble human granulomas; lack of true latency
Guinea pig/rabbit* Easy to handle, necrosis Limited availability of immunological tools; lack of true latency
Non-human primate* Lesions similar to human, LTBI established Difficult to handle, dedicated veterinarian staff required,
expensive, ethical concerns
Minipig* Pulmonary structure similar to humans, LTBI established,
lesions similar to humans
Difficult to handle, dedicated veterinarian staff required,
expensive, limited availability of immunological tools
Zebrafish embryo* Easy to handle, live, real time imaging, excellent to study
initial steps of granuloma formation
M. marinum (surrogate bacterium), lack of lung structure, lack
of lymphocytes
In vitro human Mimics human granuloma structure, flexible (mycobacterial
strains, manipulate with, e.g., cytokines, drugs), amenable
to manipulation experimentally, use for drug screening
Lack of lung structure and full tissue microenvironmental
conditions
In silico Inexpensive, flexible, long-term experiments with multiple,
complex factors can be quickly performed;
hypothesis-generating
Highly dependent on the parameters chosen, requires previous
observations in different systems to extrapolate, can miss
unknown factors, often not tested or proven
*In vivo models.
of transplanted tissue, and difficulty in applying this approach to
other animal species are major limitations of this model.
Guinea pig/rabbit
In Guinea pigs and rabbits, some granulomas are more human-
like and studies in these species have yielded important insights
on the development and structure of granulomas (Flynn, 2006).
Guinea pigs are highly susceptible to low-dose aerosol infection
and therefore do not establish a LTBI. Rabbits, despite being rela-
tively more resistant to M.tb infection, also succumb to the infec-
tion. In both models the histopathology of granulomatous lesions
is similar to that seen in progressive human disease as a strong
inflammatory response with fibrosis and intragranulomatous
necrosis followed by mineralization or even softening and lique-
faction is seen (Lenaerts et al., 2007). A down side of these models
is the relative lack of immunological tools and reagents available.
Non-human primate
The first evidence for progression from LTBI to active disease came
from the Cynomolgus macaque, a non-human primate (NHP)
model (Capuano et al., 2003). NHPs, including rhesus monkeys
and macaques, have been used as models for M.tb infection (Flynn
et al., 2003). NHPs develop a disease similar to that in humans
presenting a wide spectrum of human-like lesions and varied out-
comes to infection. In fact, NHPs are an excellent model to study
the pathogenesis and immunology of TB, as well as to screen new
vaccines, diagnostic reagents, and drug treatments for pre-clinical
studies. Some disadvantages of this model include cost, difficulty
with handling the animals, and ethical considerations.
Minipig
Recently, Gil et al. have described a model of TB infection in
minipigs (Gil et al., 2010). In this model, the most characteristic
feature is a strong local granulomatous response that is based on
the induction of a fibrotic process, where lesions are encapsulated,
and intragranulomatous necrosis and calcification are present to
help contain the dissemination of bacilli toward the alveolar space.
The initial lesions in this model show a mixture of neutrophils,
macrophages, and lymphocytes without much organization, and
very few bacilli. Over time, there is an increase in fibroblast pro-
liferation, which leads to an accumulation of myofibroblasts, and
the formation of a capsule around the granuloma, which appears
to be critical in preventing the spread of bacilli. The parenchyma
structure of the lung, characterized by extensive interlobular and
intralobular connective tissue, may play a role in the evolution of
LTBI. The fact that the local pulmonary structure in minipigs is
similar to that in humans makes it a viable model to study the
genesis of LTBI and the granulomatous response. This model is
infrequently used in the field.
Zebrafish embryo
Infection of zebrafish embryos with Mycobacterium marinum, an
aquatic, close genetic relative of M.tb, develops organized, necrotic
granulomas which appear to recapitulate human caseous granulo-
mas. Importantly, the optical transparency of the zebrafish embryo
has provided a unique tool for visualizing the dynamics of pri-
mary granuloma formation and dissemination to generate new
secondary granulomas during the innate immunity phase of the
infection in real time (Davis et al., 2002; Rubin, 2009). Although
using M. marinum instead of M.tb is a disadvantage of the model,
it provides the advantage of modeling TB in its natural host. On
the other hand, the lack of lymphocytes and lung structure are
limiting factors of this model.
IN VITRO MODELS
Several reports have described models of in vitro granuloma for-
mation using peripheral blood mononuclear cells (Franklin et al.,
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1995; Seitzer and Gerdes, 2003; Birkness et al., 2007) involv-
ing collagen matrix gels and agarose beads or agarose-coated
plates. Puissegur et al. (2004) described an in vitro granuloma
model based on human peripheral blood mononuclear cell cul-
tures either treated with mycobacterial antigen-coated beads or
infected with mycobacteria. This model demonstrates the progres-
sive recruitment of macrophages around live bacilli or mycobac-
terial antigen-coated beads, differentiation of these macrophages
into multinucleated giant cells and epithelioid cells and, finally,
recruitment of a ring of activated lymphocytes surrounding the
granuloma structure. The epithelioid cells generated in this model
have morphological and differentiation characteristics similar to
those found in natural granulomas (Lay et al., 2007). This model
has increased our knowledge about cell differentiation, cellu-
lar interactions and cell/bacteria interplay within the granuloma
structures (Peyron et al., 2008; Russell et al., 2009). These mod-
els can be used to study the initial steps of granuloma formation
and maintenance, and have the potential to address more transla-
tional aspects of human M.tb infection. On the other hand, they
lack lung structure and thus the full tissue microenvironmental
condition.
IN SILICO MODELS
In silico experimentation refers to research conducted via com-
puter simulations with models and tools that are applied to
generate new hypotheses and knowledge about biological sys-
tems. As is the case for any model, the in silico models are sys-
tems which are applied to a specific situation, and attempt to
simplify a very complex system that cannot otherwise be ade-
quately interrogated experimentally for investigation. Computer
models have been developed that describe or predict the gran-
ulomatous response outcome based on previous experimental
observations and general information about TB disease (Segovia-
Juarez et al., 2004; Fallahi-Sichani et al., 2011; Marino et al.,
2011). These models are inexpensive, very flexible, and incor-
porate a number of complex parameters. They are able to ask
questions that cannot be easily investigated in the laboratory and
generate new hypotheses. However, they are highly dependent
on the parameters chosen, require previous observations in dif-
ferent systems to extrapolate the results and can miss unknown
factors.
MODELING OTHER GRANULOMATOUS DISEASES
Granulomas usually serve to protect the host from the spread
of persistent microorganisms or other enduring injurious sub-
stances. Therefore, they are not restricted to M.tb infection; there
are other bacterial, fungal, and viral infections, and even non-
infectious inflammatory diseases characterized by the presence
of granulomas (Sandor et al., 2003). Some of the better studied
granulomatous responses relate to other infectious diseases, neo-
plastic processes, and autoimmune inflammatory diseases. Below
is a brief summary of some of them and their main characteristics:
- Leprosy: caused by Mycobacterium leprae and characterized by
the presence of acid-fast bacilli within macrophages in granu-
lomas. The most commonly used models are mice, armadillos,
and mathematical models (Scollard et al., 2006; Adams et al.,
2012).
- Syphillis: caused by Treponema pallidum and characterized by
the presence of gumma, a microscopic to grossly visible lesion,
enclosing a wall of histiocytes, with plasma cell infiltrates and
central necrosis without loss of cellular outline. The most com-
monly used models are hamster and mathematical models
(Kajdacsy-Balla et al., 1993; Gesink Law et al., 2006).
- Sarcoidosis: caused by an unknown etiology (although
mycobacterial antigens have long been implicated) and charac-
terized by non-caseating granulomas with abundant activated
macrophages. The most commonly used model is the murine
model of antigen-driven granuloma formation (Samokhin et al.,
2011; Yeager et al., 2012).
- Crohn’s disease: caused by immune reaction against intestinal
bacteria and/or self-antigens and characterized by non-caseating
granulomas in the wall of the intestine, with dense chronic
inflammatory infiltrate. The most commonly used model is the
murine model of chronic inflammation (Dillman et al., 2013;
Tlaxca et al., 2013).
- Schistosomiasis: caused by Schistosoma ssp. and characterized by
hepatic granuloma formation with fibrosis initiated by MHC-
II-dependent,α/β+ CD4+ T lymphocytes. The most commonly
used model is the SEA (Schistosoma egg antigen)-specific dri-
ven granuloma in mouse, monkey, and baboon animal models
(Stavitsky, 2004).
Despite the extreme diversity in their etiology, several of the
above diseases share general underlying histopathologic character-
istics of granuloma lesions. Thus, the knowledge obtained about
mycobacterial granulomas and some of the models used to study
them may be useful in advancing knowledge about these other
diseases.
CONCLUSION
This review has described a variety of experimental models avail-
able that can help decipher the complex host-pathogen relation-
ship that takes place within the tuberculous granuloma. Although
the mycobacterial granuloma seems to be a host defense mecha-
nism for walling off M.tb, the bacilli can also survive, protected
from killing by immune cells, and persist in a latent form until
an opportunity arises for reactivation and dissemination (Grosset,
2003). An understanding of the pathophysiology of granulomas
is critical for the design of new TB drugs and vaccines. Different
models are necessary to cover the wide histopathological spectrum
of mycobacterial granulomas observed. Each model described in
this review has and, by further development, will continue to make
important contributions to TB research. The luxury of having
many available models, however, must be weighed against a careful
interpretation of the data obtained from them. Given the advan-
tages and disadvantages of each model, it seems most likely that
our understanding of the mycobacterial granuloma will be derived
from a combination of models. Granulomas are not only present
in mycobacterial infections, they can be found in many other
bacterial, fungal, parasitic, or viral infections, and even in non-
infectious, inflammatory granulomatous diseases (Sandor et al.,
2003). Therefore, the knowledge obtained from analyzing models
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of mycobacterial granulomas may prove to be beneficial for uncov-
ering mechanisms for other granulomatous diseases, including
investigation of distinct infectious disease phenotypes and autoim-
mune as well as auto-inflammatory granulomatous diseases (e.g.,
Crohn’s disease or sarcoidosis).
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